Both in Biotechnology
Gilead Sciences vs Amgen
Over the past year GILD returned +34.3% and AMGN returned +54.6%; their daily moves had a correlation of 0.47.
GILD +34.3% AMGN +54.6%Growth of $1, one year, split-adjusted
| Metric | GILD | AMGN |
|---|---|---|
| Price | $151.28 | $423.64 |
| Market cap | $187.58B | $229.03B |
| Today | −0.61% | +1.32% |
| 1 month | +3.8% | −2.0% |
| 6 months | +11.0% | +21.4% |
| Year to date | +23.3% | +29.4% |
| 1 year | +35.0% | +55.2% |
| Revenue growth (YoY) | +10.2% | +9.5% |
| Gross margin | 79.8% | 72.0% |
| Net margin | −134.5% | 23.6% |
| P/E (TTM) | — | 26.2× |
| Price / sales | 6.2× | 6.0× |
| Net cash | -$23.07B | -$43.31B |
| Dividend yield | 2.17% | 2.38% |
| Volatility (60d) | 26.8% | 33.8% |
| Short % of float | 1.5% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).